TheEdgeResearch
Home / Stocks / PCLOF

PharmaCielo Ltd. (PCLOF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.05 ▼ -15.51%
Market Cap
$8.5M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.02
52-Wk Range
0.004-0.117
CEO
Marc Lustig
Country
CA
Currency
USD

PharmaCielo Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.05, down 15.51% on the session, giving a market capitalisation of $8.5M. On trailing twelve-month figures it carries a trailing P/E of -3.49, a net margin of -141.1%. Its beta of 1.02 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.49
Price / Sales
4.82
Price / Book
-1.18
EV / EBITDA
-77.90
Gross margin
29.6%
Operating margin
-127.5%
Net margin
-141.1%
Return on equity
Debt / equity
-1.74
Current ratio
0.15
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
268
IPO date
2019-01-25
Headquarters
Toronto, ON, CA
About PharmaCielo Ltd.

PharmaCielo Ltd., operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition, the company provides telemedicine software solutions. Its diverse clientele comprises health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies across Canada and Colombia. PharmaCielo Ltd. maintains a strategic alliance with AssuredTrans Inc., and its corporate headquarters are located in Toronto, Canada.

Comparable companies

PharmaCielo Ltd. is most often compared with the following Healthcare names:

AUSAFAVTBFBBRRFBUDZCANNCPIVFIONKFLOBEFTHCBFVDQSF
More research on PCLOF
PCLOF technical analysis PCLOF TheEdge Score Compare against peers
Open full interactive analysis & DCF →